Get the Stockscreener App
8.995
3.38%
-0.325
Rezolute Inc stock is traded at $8.995, with a volume of 829.54K.
It is down -3.38% in the last 24 hours and down -1.04% over the past month.
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
See More
Previous Close:
$9.32
Open:
$9.29
24h Volume:
829.54K
Relative Volume:
0.69
Market Cap:
$817.76M
Revenue:
-
Net Income/Loss:
$-69.31M
P/E Ratio:
-7.0827
EPS:
-1.27
Net Cash Flow:
$-62.80M
1W Performance:
-4.71%
1M Performance:
-1.04%
6M Performance:
+125.13%
1Y Performance:
+63.73%
1-Day Range:
$8.97
$9.4762
1-Week Range:
$8.97
$10.03
52-Week Range:
$2.215
$10.04
Rezolute Inc Stock (RZLT) Company Profile
Name
Rezolute Inc
Sector
Industry
Phone
650-206-4507
Address
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Compare RZLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
9.005 | 846.52M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.52 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.42 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.79 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.21 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.05 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Initiated | Wedbush | Outperform |
| Aug-27-24 | Initiated | Guggenheim | Buy |
| Jul-17-24 | Initiated | BTIG Research | Buy |
| Jun-04-24 | Initiated | Craig Hallum | Buy |
| Apr-09-24 | Initiated | Maxim Group | Buy |
| Aug-02-22 | Resumed | Canaccord Genuity | Buy |
| Jun-15-22 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-08-21 | Initiated | ROTH Capital | Buy |
| May-27-21 | Initiated | Oppenheimer | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
View All
Rezolute Inc Stock (RZLT) Latest News
Can Rezolute Inc. (6HV1) stock sustain breakout momentum2025 Winners & Losers & Verified Swing Trading Watchlists - newser.com
Analyzing drawdowns of Rezolute Inc. with statistical toolsQuarterly Earnings Summary & Low Risk Entry Point Guides - newser.com
Can Rezolute Inc. (6HV1) stock deliver double digit returnsPortfolio Risk Summary & Safe Swing Trade Setup Alerts - newser.com
Will Rezolute Inc. stock remain a Wall Street favoriteMarket Sentiment Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Will Rezolute Inc. stock split again soon2025 Support & Resistance & Capital Protection Trading Alerts - newser.com
Will Rezolute Inc. bounce back from current supportProduct Launch & Verified Momentum Stock Alerts - newser.com
Is Rezolute Inc. stock a buy for dividend growthMarket Volume Report & Advanced Swing Trade Entry Plans - newser.com
Will Rezolute Inc. stock benefit from infrastructure spendingTrade Risk Report & Long-Term Safe Return Strategies - newser.com
Using RSI to spot recovery in Rezolute Inc.July 2025 Review & Entry Point Confirmation Alerts - newser.com
Momentum divergence signals in Rezolute Inc. chartBond Market & Safe Capital Growth Tips - newser.com
Price momentum metrics for Rezolute Inc. explainedQuarterly Investment Review & Daily Growth Stock Tips - newser.com
Rezolute, Inc. (RZLT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
What drives Rezolute Inc stock priceMoving Average Crossovers & Free Harness Proven Investment Plans - earlytimes.in
Technical signs of recovery in Rezolute Inc.2025 Biggest Moves & Weekly Momentum Stock Picks - newser.com
Rezolute (RZLT) to Release Quarterly Earnings on Thursday - MarketBeat
Is Rezolute Inc. stock a good choice for value investorsWeekly Investment Summary & Low Volatility Stock Recommendations - newser.com
How Rezolute Inc. (6HV1) stock stacks up against competitors2025 Market Sentiment & AI Driven Stock Movement Reports - newser.com
Citizens Jmp Issues Positive Forecast for Rezolute (NASDAQ:RZLT) Stock Price - MarketBeat
RZLT Shares Rise 30.8% in 6 Months: What's Driving the Rally? - MSN
Applying Wyckoff theory to Rezolute Inc. stock2025 Market Overview & Growth Focused Investment Plans - newser.com
Rezolute (RZLT) Sees Analyst Raises Price Target to $17.00 | RZL - GuruFocus
Is Rezolute Inc. (RZLT) One of the Top Long-Term Biotechnology Stocks to Buy - Insider Monkey
Will Rezolute Inc. stock outperform Dow Jones index2025 Stock Rankings & Safe Entry Point Identification - fcp.pa.gov.br
Rezolute Inc Stock (RZLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Rezolute Inc Stock (RZLT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Evans Daron | CFO |
Jun 24 '25 |
Buy |
4.05 |
5,000 |
20,250 |
268,900 |
| Kim Young-Jin | Director |
Jun 13 '25 |
Buy |
3.25 |
1,230,769 |
3,999,999 |
8,423,386 |
| KREHER NERISSA | Director |
Jun 13 '25 |
Buy |
3.25 |
3,076 |
9,997 |
37,576 |
| Hogenhuis Wladimir | Director |
Mar 31 '25 |
Buy |
2.92 |
6,758 |
19,733 |
84,025 |
| Elam Nevan C | CEO |
Mar 27 '25 |
Buy |
2.85 |
12,302 |
34,999 |
224,119 |
| Evans Daron | CFO |
Mar 26 '25 |
Buy |
2.89 |
10,000 |
28,900 |
237,900 |
| Evans Daron | CFO |
Mar 26 '25 |
Buy |
2.88 |
10,000 |
28,800 |
23,000 |
| Hogenhuis Wladimir | Director |
Feb 18 '25 |
Buy |
4.70 |
10,000 |
47,000 |
77,267 |
| Evans Daron | CFO |
Dec 18 '24 |
Buy |
4.29 |
10,000 |
42,900 |
150,900 |
| Evans Daron | CFO |
Dec 12 '24 |
Buy |
4.60 |
9,000 |
41,400 |
140,900 |
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):